Refine by MP, party, committee, province, or result type.
Health committee I really believe we need a firewall between industry and what prescribers are told. We cannot take at face value what they tell us about the drug.
December 4th, 2013Committee meeting
Ada Giudice-Tompson
Health committee Yes.
December 4th, 2013Committee meeting
Ada Giudice-Tompson
Health committee What I was envisioning was that we have a group of experts who assist Health Canada. Right now what happens is there are clinical trials conducted by drug companies, and Health Canada accepts that information as gospel. We really don't get to see the harm or the effects of that m
December 4th, 2013Committee meeting
Ada Giudice-Tompson
Health committee I believe so, I'm sad to say. Health Canada probably doesn't have the staff, but why do we need all this generic oxycodone when Health Canada has pulled from the formulary OxyContin? They've replaced it with OxyNEO, which is more tamper resistant. However, that doesn't mean it's
December 4th, 2013Committee meeting
Ada Giudice-Tompson
Health committee Perfect.
December 4th, 2013Committee meeting
Ada Giudice-Tompson
Health committee I believe you said the third recommendation, correct? That's the abolition of specific marketing practices for prescription drugs with potential for abuse. In the 1990s, Purdue Pharma conducted a massive campaign. They had the brand name OxyContin, but they promoted the use of
December 4th, 2013Committee meeting
Ada Giudice-Tompson
Health committee It's Giudice, like a girl's first name.
December 4th, 2013Committee meeting
Ada Giudice-Tompson
Health committee Mr. Chairman, and members of the committee, good afternoon and thank you for the opportunity to provide testimony. My name is Ada Giudice-Tompson. I am vice-president of Advocates for the Reform of Prescription Opioids, and I serve as a member of CCSA's National Advisory Counci
December 4th, 2013Committee meeting
Ada Giudice-Tompson